• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[用于慢性静脉疾病的处方药的药理学]

[Pharmacology of the drugs prescribed for chronic venous diseases].

作者信息

Talibov O B

机构信息

Evdokimov Moscow State University of Medicine and Dentistry, Chair of Therapy, Clinical Pharmacology and Emergency Medical Care, Moscow, Russia.

出版信息

Khirurgiia (Mosk). 2019(2):106-109. doi: 10.17116/hirurgia2019021106.

DOI:10.17116/hirurgia2019021106
PMID:30855600
Abstract

The main groups of the drugs used for pharmacotherapy of chronic venous disease are considered. The main therapeutic targets of the drugs including their effect on venous wall tone, permeability and inflammation are described.

摘要

本文考虑了用于慢性静脉疾病药物治疗的主要药物类别。描述了这些药物的主要治疗靶点，包括它们对静脉壁张力、通透性和炎症的影响。

相似文献

1
[Pharmacology of the drugs prescribed for chronic venous diseases].[用于慢性静脉疾病的处方药的药理学]
Khirurgiia (Mosk). 2019(2):106-109. doi: 10.17116/hirurgia2019021106.
2
Flavonoids. A review of the pharmacology and therapeutic efficacy of Daflon 500 mg in patients with chronic venous insufficiency and related disorders.类黄酮。500毫克微粒化纯化黄酮成分（爱脉朗）治疗慢性静脉功能不全及相关疾病的药理学与疗效综述。
Angiology. 1994 Jun;45(6):419-28. doi: 10.1177/000331979404500602.
3
[Diosmin in the treatment of venous disease: pharmacokinetics and pharmacodynamics (in Russian only)].地奥司明治疗静脉疾病：药代动力学与药效学（仅俄文版）
Khirurgiia (Mosk). 2019(3):135-140. doi: 10.17116/hirurgia2019031135.
4
Are the phlebotonic properties shown in clinical pharmacology predictive of a therapeutic benefit in chronic venous insufficiency? Our experience with Daflon 500 mg.临床药理学中显示的促静脉回流特性能否预测对慢性静脉功能不全的治疗益处？我们使用达弗隆500毫克的经验。
Int Angiol. 1989 Oct-Dec;8(4 Suppl):53-9.
5
Clinical and hemodynamic outcomes in patients with chronic venous insufficiency after oral micronized flavonoid therapy.口服微粉化黄酮类药物治疗慢性静脉功能不全患者的临床和血流动力学结果
Vasc Surg. 2001 Nov-Dec;35(6):443-7. doi: 10.1177/153857440103500604.
6
[Possibilities of pharmacotherapy for chronic venous insufficiency with diosmin preparations from the position of the endothelial functional state].从内皮功能状态角度看地奥司明制剂对慢性静脉功能不全的药物治疗可能性
Angiol Sosud Khir. 2015;21(3):91-4, 96-7.
7
Three treatments for chronic venous insufficiency: escin, hydroxyethylrutoside, and Daflon.慢性静脉功能不全的三种治疗方法：七叶皂苷、羟乙基芦丁和地奥司明。
Angiology. 2000 Mar;51(3):197-205. doi: 10.1177/000331970005100303.
8
Therapeutic potential of flavonoids in the treatment of chronic venous insufficiency.类黄酮在治疗慢性静脉功能不全中的治疗潜力。
Vascul Pharmacol. 2021 Apr;137:106825. doi: 10.1016/j.vph.2020.106825. Epub 2020 Dec 2.
9
Pharmacological treatment of primary chronic venous disease: rationale, results and unanswered questions.原发性慢性静脉疾病的药物治疗：原理、结果及未解问题。
Eur J Vasc Endovasc Surg. 2011 Jan;41(1):117-25. doi: 10.1016/j.ejvs.2010.09.025. Epub 2010 Dec 3.
10
[Value of semisynthetic diosmin in chronic venous insufficiency].
LARC Med. 1982 Jul-Aug;2(7):609-10.